Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1834-1842

  Trougakos, Ioannis P ^a   So, Alan ^b   Jansen, Burkhard ^b   Gleave, Martin E ^b   Gonos, Efstathios S ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLUSTERIN; HYDROGEN PEROXIDE; OLIGONUCLEOTIDE; PACLITAXEL; SMALL INTERFERING RNA; CHAPERONE; CLU PROTEIN, HUMAN; GLYCOPROTEIN;

APOPTOSIS; ARTICLE; CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENOTOXICITY; HOMEOSTASIS; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA DEGRADATION; STEADY STATE; CELL DIVISION; DRUG EFFECT; GENETICS; MALE; METABOLISM; NEOPLASM; OSTEOSARCOMA; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CLUSTERIN; GENE SILENCING; GLYCOPROTEINS; HUMANS; MALE; MOLECULAR CHAPERONES; NEOPLASMS; OSTEOSARCOMA; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING;

EID: 1642282641     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2664     Document Type: Article

References (61)

1. Jenne, D. E., and Tschopp, J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem. Sci., 17: 154-159, 1992.
2. De Silva, H. V., Harmony, J. A. K., Stuart, W. D., Gil, C. M., and Robbins, J. Apolipoprotein J: structure and tissue distribution. Biochemistry, 29: 5380-5389, 1990.
3. Trougakos, I. P., and Gonos, E. S. Clusterin/Apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol., 34: 1430-1448, 2002.
4. Yang, C-R., Leskov, K., Hosley-Eberlein, K., Criswell, T., Pink, J. J., Kinsella, T. J., and Boothman, D. A. Nuclear clusterin/XIPS, an x-ray-induced Ku70-binding protein that signals cell death. Proc. Natl. Acad. Sci. USA, 97: 5907-5912, 2000.
5. Leskov, K. S., Klokov, D. Y., Li, J. Kinsella, T. J., and Boothman, D. A. Synthesis and functional analysis of nuclear clusterin: a cell death protein. J. Biol. Chem., 278: 11590-11600, 2003.
6. Rosenberg, M. E., and Silkensen, J. Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol., 27: 633-645, 1995.
7. Koch-Brandt, C., and Morgans, C. Clusterin: a role in cell survival in the face of apoptosis? Prog. Mol. Subcell. Biol., 16: 130-149, 1996.
8. Poon, S., Easterbrook-Smith, S. B., Rybchyn, M. S., Carver, J. A., and Wilson, M. R. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry, 39: 15953-15960, 2000.
9. Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., and Ghiso, J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech., 50: 305-315, 2000.
10. Parczyk, K., Pilarsky, C., Rachel, U., and Koch-Brand, C. Gp80 (clusterin: TRPM-2) mRNA levels is enhanced in human renal clear cell carcinomas. J. Cancer Res. Clin. Oncol., 120: 186-188, 1994.
11. Steinberg, J., Oyasu, R., Lang, S., Sintich, S., Rademaker, A., Lee, C., Kozlowski, J. M., and Sensibar, J. A. Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res., 3: 1707-1711, 1997.
12. Wellmann, A., Thieblemont, C., Pittaluga, S., Sakai, A., Jaffe, E. S., Siebert, P., and Raffeld, M. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood. 96: 398-404, 2000.
13. Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R., and Morin, P. J. Coordinately up-regulated genes in ovarian cancer. Cancer Res., 61: 3869-3876, 2001.
14. Ouyang, X. S., Wang, X., Lee, D. T., Tsao, S. W., and Wong, Y. C. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis (Lond.), 22: 965-973, 2001.
15. Redondo, M., Villar, E., Torres-Muñoz, J., Tellez, T., Morell, M., and Petito, C. Overexpression of clusterin in human breast carcinoma. Am. J. Pathol., 157: 393-399, 2000.
16. Wehrli, P., Chamay, Y., Vallet, P., Zhu, G., Harmony, J., Aronow, B., Tschopp, J., Bouras, C., Viard-Leveugle, I., French, L. E., and Giannakopoulos, P. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat. Med., 7: 977-978, 2001.
17. Han, B. H., DeMattos, R. B., Dugan, L. L., Kim-Han, J. S., Brendza, R. P., Fryer, J. D., Kierson, M., Cirrito, J., Quick, K., Harmony, J. A., Aronow, B. J., and Holtzman, D. M. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat. Med., 7: 338-343, 2001.
18. Buttyan, R., Olsson, C. A., Pintar, J., Chang, C., Bandyk, M., Ng, P. Y., and Sawczyk, I. S. Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol. Cell. Biol., 9: 3473-3481, 1989.
19. Lakins J., Bennett, S. A. L., Chen, J-H., Arnold, J. M., Morrissey, C., Wong, P., Sullivan, J. O'., and Tenniswood, M. Clustering biogenesis is altered during apoptosis in the regressing rat ventral prostate. J. Biol. Chem., 273: 27887-27895, 1998.
20. Kalka, K., Ahmad, N., Criswell, T., Boothman, D., and Mukhtar, H. Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res., 60: 5984-5987, 2000.
21. Gonos, E. S., Derventzi, A., Kveiborg, M., Agiostratidou, G., Kassem, M., Clark, B. F. C., Jat, P. S., and Rattan, S. I. S. Cloning and identification of genes that associate with mammalian senescence. Exp. Cell Res., 240: 66-74, 1998.
22. Petropoulou, C., Trougakos, I. P., Kolettas, E., Toussaint, O., and Gonos, E. S. Clusterin/Apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett., 509: 287-297, 2001.
23. Dumont, P., Chainiaux, F., Eliaers, F., Petropoulou, C., Remacle, J., Koch-Brandt, C., Gonos, E. S., and Toussaint, O. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induce by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones, 7: 23-35, 2002.
24. Trougakos, I. P., Poulakou, M., Stathatos, M., Chalikia, A., Melidonis, A., and Gonos, E. S. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp. Gerontol., 37: 1175-1187, 2002.
25. Miyake, H., Nelson, C., Rennie, P. S., and Gleave, M. E. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res., 60: 170-176, 2000.
26. Miyake, H., Nelson, C., Rennie, P. S., and Gleave, M. E. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res., 60: 2547-2554, 2000.
27. Miyake, H., Chi, K. N., and Gleave, M. E. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin. Cancer Res., 6: 1655-1663, 2000.
28. Zellweger, T., Miyake, H., Cooper, S., Chi, K., Conklin, B. S., Monia, B., and Gleave, M. E. Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-o-(2-methoxy) ethyl chemistry. J. Pharmacol. Exp. Ther., 298: 934-940, 2001.
29. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., and Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci., 114: 4557-4565, 2001.
30. Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P., and Sharp, P. A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev., 13: 3191-3197, 1999.
31. Isfort, R. J., Cody, D. B., Lovell, G., and Doersen, C. J. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines. Mol. Carcinog., 14: 170-178, 1995.
32. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A-L., and Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet., 34: 263-263, 2003.
33. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., and Williams, B. R. G. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol., 5: 834-839, 2003.
34. Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. Rev., 14: 778-809, 2001.
35. Kloetzel, P-M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell. Biol., 2: 179-187, 2001.
36. Chi, J-T., Chang, H. Y., Wang, N. N., Chang, D. S. Dunphy, N., and O'Brown, P. Genome-wide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA, 100: 6343-6346, 2003.
37. Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., and Fesik, S. W. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA, 100: 6347-6352, 2003.
38. Gewirtz, D. A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem. Pharmacol., 57: 727-741, 1999.
39. Muller, C., Chatelut, E., Gualano, V., De Forni, M., Huguet, F., Attal, M., Canal, P., and Laurent, G. Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion. Cancer Chemother. Pharmacol., 32: 379-384, 1993.
40. Rohlff, C., Blagosklonny, M. V., Kyle, E., Kesari, A., Kim, I. Y., Zelner, D. J., Hakim, F., Trepel, J., and Bergan, R. C. Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21 (waf1/cip1). Prostate, 37: 51-59, 1998.
41. Miyake, H., Gleave, M. E., Arakawa, S., Kamidono, S., and Hara, I. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential. J. Urol., 167: 2203-2208, 2002.
42. Garden, G. A., Bothwell, M., and Rubel, E. W. Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J. Neurobiol., 22: 590-604, 1991.
43. O'Bryan, M. K., Cheema, S. S., Bartlett, P. F., Murphy, B. F., and Pearse, M. J. Clusterin levels increase during neuronal development. J. Neurobiol., 24: 421-432, 1993.
44. Aronow, B. J., Lund, S. D., Brown, T. L., Harmony, J. A. K., and Witte, D. P. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. USA, 90: 725-729, 1993.
45. Miyake, H., Hara, I., Kamidono, S., and Gleave, M. E. Synergistic chemosensitization and inhibition of tumour growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin. Can. Res., 7: 4245-4252, 2001.
46. Zellweger, T., Miyake, H., July, L., Akbari, M., Kiyama, S., and Gleave, M. E. Chemosensitization of a human renal cell cancer model by antisense TRPM-2 oligodeoxynucleotides both in vitro and in vivo. Neoplasia, 3: 1-8, 2001.
47. McLaughlin, L., Zhu, G., Mistry, M., Ley-Ebert, C., Stuart, W. D., Florio, C. J., Groen, P. A., Witt, S. A., Kimball, T. R., Witte, D. P., Harmony, J. A. K., and Aronow, B. J. Apolipoprotein J/Clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Investig., 106: 1105-1113, 2000.
48. Bailey, R. W., Aronow, B., Harmony, J. A., and Griswold, M. D. Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol. Reprod., 66: 1042-1053, 2002.
49. Rosenberg, M. E., Girton, R., Finkel, D., Chmielewski, D., Barie, A., III, Witte, D. P., Zhu, G., Bissler, J. J., Harmony, J. A. K., and Aronow, B. Apolipoprotein J/Clusterin prevents a progressive glomerulopathy of aging. Mol. Cell. Biol., 22: 1893-1902, 2002.
50. Bettuzzi, S., Scorcioni, F., Astancolle, S., Davalli, P., Scaltriti, M., and Corti, A. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene, 21: 4328-4334, 2002.
51. Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J., and Dove, W. F. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl. Acad. Sci. USA, 100: 9530-9535, 2003.
52. Humphreys, D., Hochgrebe, T. T., Easterbrook-Smith, S. B., Tenniswood, M. P., and Wilson, M. R. Effects of clusterin overexpression on TNFα- and TGFβ-mediated death of L929 cells. Biochemistry, 36: 15233-15243, 1997.
53. O'Sullivan, J., Whyte, L., Drake, J., and Tenniswood, M. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ., 10: 914-927, 2003.
54. Debure, L., Vayssiere, J. L., Rincheval, V., Loison, F., Le Drean, Y., and Michel, D. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J. Cell Sci., 116: 3109-3121, 2003.
55. Silkensen, J. R., Skubitz, K. M., Skubitz, A. P. N., Chmielewaki, D. H., Manivel, J. C., Dvergsten, J. A., and Rosenberg, M. E. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J. Clin. Investig., 96: 2646-2653, 1995.
56. Millis, A. J. T., Luciani, M., McCue, H. M., Rosenberg, M. E., and Moulson, C. L. Clusterin regulates vascular smooth muscle cell nodule formation and migration. J. Cell. Physiol., 186: 210-219, 2001.
57. Jiang, Z., Zheng, X., and Rich, K. M. Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. J. Neurochem., 84: 273-281, 2003.
58. Tiberio, R., Marconi, A., Fila, C., Fumelli, C., Pignatti, M., Krajewski, S., Giannetti, A., Reed, J. C., and Pincelli, C. Keratinocytes enriched for stem cells are protected from anoikis via an integrin signaling pathway in a Bcl-2 dependent manner. FEBS Lett., 524: 139-144, 2002.
59. Rosen, K., Rak, J., Leung, T., Dean, N. M., Kerbel, R. S., and Filmus, J. Activated Ras prevents down-regulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol., 149: 447-456, 2000.
60. Vitale, M., Di Matola, T., Bifulco, M., Casamassima, A., Fenzi, G., and Rossi, G. Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. FEBS Lett., 462: 57-60, 1999.
61. Jiang, M., and Milner, J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev., 17: 832-837, 2003.